MACH7 TECHNOLOGIES LIMITED — Capital/Financing Update 2019

Aug 13, 2019

ASX Announcement

14 August 2019

==> picture [612 x 88] intentionally omitted <==

New Contracts Affirm Sales Strategy

New contracts recently signed:

• Colorado Imaging Associates

• UW Medicine

• Sentara Halifax Regional Hospital

Melbourne, Australia; 14 August 2019: Mach7 Technologies Limited (Mach7 or the Company) (ASX:M7T) is pleased to announce it has recently won three new contracts with a combined total contract value of approximately A$0.5 million.

Sales Strategy Progress

These new contracts further consolidate a strong sales quarter, following the $5.7 million minimum total contract value deal with Advocate Aurora Health announced last month.

Importantly, the contracts demonstrate the Mach7 Platform can be used to provide a complete enterprise imaging strategy, including a modern approach to radiology PACS, whilst solving interoperability issues healthcare organizations are facing with their existing technologies.

These contracts are further proof that hospital consolidation and supply chain optimisation are growth catalysts for the enterprise imaging market. Mach7 is well-positioned to assist potential clients through every stage of their enterprise journey and the Company is continuing to make inroads with both new and existing customers to realize this goal. These recent wins, as outlined below, affirm Mach7’s commercial strategy and that the market is responding to the innovative solutions offered by Mach7.

Colorado Imaging Associates

Colorado Imaging Associates (CIA) is a radiology services company based in Golden, Colorado. CIA have purchased the Mach7 Platform to augment its current technology with smart routing and niche workflow capabilities that are common among reading groups and teleradiology providers across the United States.

UW Medicine

UW Medicine (UWM), a health system in Seattle, Washington, recently acquired an existing Mach7 customer, and saw the value in the Mach7 Platform. As a result, UWM has purchased a license to expand its use of the Mach7 Platform from this single facility into their greater health system. The Mach7 Platform will provide interoperability workflows between their modalities (CT, MRI, etc.) and

==> picture [610 x 89] intentionally omitted <==

ASX Announcement

14 August 2019

==> picture [612 x 88] intentionally omitted <==

their existing PACS systems. In addition, the health system sees the value of the Mach7 Platform as a solution that will allow it to grow and solve many of their current challenges.

Sentara Halifax Regional Hospital

Sentara Healthcare, Mach7’s long-time customer, has contracted with Mach7 to migrate approximately 700,000 studies from its PACS at one of their recently-acquired hospitals, Sentara Halifax Regional Hospital. This is part of the process of fully implementing the modernized PACS solution at Sentara by Mach7 and its business partner, Client Outlook.

FY19 Results

The Company looks forward to reporting its audited 2019 financial results during the week beginning 26 August 2019.

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T) develops innovative data management solutions that create a clear and complete view of the patient to inform diagnosis, reduce care delivery delays and costs, and improve patient outcomes. Mach7’s awardwinning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and communication to power interoperability and enables healthcare enterprises to build their best-of-breed clinical ecosystems. Mach7’s sophisticated workflow tools, advanced clinical viewing and optimized vendor neutral archiving solutions unlock silos of legacy systems empowering healthcare providers to own, access and share patient data without boundaries. Visit Mach7t.com.

For more information, contact :

Jenni Pilcher Andrew Keys CFO, Mach7 Investor Relations jenni.pilcher@mach7t.com andrew.keys@keysthomas.com

==> picture [610 x 89] intentionally omitted <==